MedPath
NMPA Approval

Compound Pholcodine Oral Solution

国药准字HC20150060

September 5, 2024

HC20150060

Drug Information

复方福尔可定口服溶液

澳特斯

口服溶液剂

每5ml含福尔可定5.0mg,盐酸曲普利啶0.6mg,盐酸伪麻黄碱15.0mg和愈创木酚甘油醚50.0mg。

化学药品

September 5, 2024

September 4, 2029

Company Information

Applicant Company

香港新界元朗工业村宏富街1&8号澳美制药中心

Manufacturing Company

香港新界元朗工业村宏富街1号澳美制药中心

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方福尔可定口服溶液 - NMPA 批准文号 | MedPath